Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bayes-Genis

Showing results (501-510 of 645) with videos related to

Pageof 65
Sort By:
Tissue Engineering. Part C, Methods|July 13, 2017
Preclinical Safety Evaluation of Allogeneic Induced Pluripotent Stem Cell-Based Therapy in a Swine Model of Myocardial InfarctionCarolina Gálvez-Montón, Carolina Soler-Botija, Oriol Iborra-Egea, et al.
European Journal of Heart Failure|September 9, 2021
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)Wouter C Meijers, Antoni Bayes-Genis, Alexandre Mebazaa, et al.
European Journal of Heart Failure|December 12, 2025
Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus documentAmr Abdin, Johann Bauersachs, Magdy Abdelhamid, et al.
European Journal of Heart Failure|March 22, 2024
Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology PracticeGianluigi Savarese, Felix Lindberg, Ruxandra M Christodorescu, et al.
Circulation. Arrhythmia and Electrophysiology|April 26, 2024
Antiarrhythmic and Anti-Inflammatory Effects of Sacubitril/Valsartan on Post-Myocardial Infarction ScarDaina Martínez-Falguera, Júlia Aranyó, Albert Teis, et al.
ESC Heart Failure|November 12, 2022
Time course, factors related to, and prognostic impact of venoarterial extracorporeal membrane flow in cardiogenic shockSantiago Montero, Mercedes Rivas-Lasarte, Florent Huang, et al.
Heart Rhythm|November 2, 2015
Interatrial block and atrial arrhythmias in centenarians: Prevalence, associations, and clinical implicationsManuel Martínez-Sellés, Albert Massó-van Roessel, Jesús Álvarez-García, et al.
Journal of Clinical Medicine|July 31, 2020
Short- and Long-Term Mortality Trends in STEMI-Cardiogenic Shock over Three Decades (1989-2018): The Ruti-STEMI-Shock RegistryCosme García-García, Teresa Oliveras, Nabil El Ouaddi, et al.
European Journal of Heart Failure|December 15, 2024
The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high-, middle- and low-income countries - A Global Congestive Heart Failure (G-CHF) studyDarryl P Leong, Philip G Joseph, Hisham Dokainish, et al.
European Heart Journal. Acute Cardiovascular Care|April 6, 2021
Awake venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shockSantiago Montero, Florent Huang, Mercedes Rivas-Lasarte, et al.
Pageof 65

Showing results (501-510 of 645) with videos related to

Sort By:
Pageof 65
Tissue Engineering. Part C, Methods|July 13, 2017
Preclinical Safety Evaluation of Allogeneic Induced Pluripotent Stem Cell-Based Therapy in a Swine Model of Myocardial InfarctionCarolina Gálvez-Montón, Carolina Soler-Botija, Oriol Iborra-Egea, et al.
European Journal of Heart Failure|September 9, 2021
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)Wouter C Meijers, Antoni Bayes-Genis, Alexandre Mebazaa, et al.
European Journal of Heart Failure|December 12, 2025
Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus documentAmr Abdin, Johann Bauersachs, Magdy Abdelhamid, et al.
European Journal of Heart Failure|March 22, 2024
Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology PracticeGianluigi Savarese, Felix Lindberg, Ruxandra M Christodorescu, et al.
Circulation. Arrhythmia and Electrophysiology|April 26, 2024
Antiarrhythmic and Anti-Inflammatory Effects of Sacubitril/Valsartan on Post-Myocardial Infarction ScarDaina Martínez-Falguera, Júlia Aranyó, Albert Teis, et al.
ESC Heart Failure|November 12, 2022
Time course, factors related to, and prognostic impact of venoarterial extracorporeal membrane flow in cardiogenic shockSantiago Montero, Mercedes Rivas-Lasarte, Florent Huang, et al.
Heart Rhythm|November 2, 2015
Interatrial block and atrial arrhythmias in centenarians: Prevalence, associations, and clinical implicationsManuel Martínez-Sellés, Albert Massó-van Roessel, Jesús Álvarez-García, et al.
Journal of Clinical Medicine|July 31, 2020
Short- and Long-Term Mortality Trends in STEMI-Cardiogenic Shock over Three Decades (1989-2018): The Ruti-STEMI-Shock RegistryCosme García-García, Teresa Oliveras, Nabil El Ouaddi, et al.
European Journal of Heart Failure|December 15, 2024
The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high-, middle- and low-income countries - A Global Congestive Heart Failure (G-CHF) studyDarryl P Leong, Philip G Joseph, Hisham Dokainish, et al.
European Heart Journal. Acute Cardiovascular Care|April 6, 2021
Awake venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shockSantiago Montero, Florent Huang, Mercedes Rivas-Lasarte, et al.
Pageof 65